Yasuhiro Okumura

Yasuhiro Okumura

Auto-generated profile, based on publicly available information

Yasuhiro Okumura

Division of Digestive Surgery, Nihon University School of Medicine, Itabashi, Japan

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
YOYasuhiro Okumura
Yasuhiro Okumura
Hiroharu YamashitaHiroharu Yamashita
Hiroharu Yamashita
SASusumu Aikou
Susumu Aikou
KYKoichi Yagi
Koichi Yagi
YYYukinori Yamagata
Yukinori Yamagata
YSYasuyuki Seto
Yasuyuki Seto
Either palliative distal gastrectomy or gastrojejunostomy are the initial treatment options for locally advanced gastric cancer with outlet obstruction when curative-intent resection is not feasible. Since chemotherapy is the mainstay for unresectable gastric cancer, the clinical value of palliative distal gastrectomy is controversial.

1 January 2018 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
YOYasuhiro Okumura
Yasuhiro Okumura
MTManabu Takamatsu
Manabu Takamatsu
MOManabu Ohashi
Manabu Ohashi
YYYorimasa Yamamoto
Yorimasa Yamamoto
NYNoriko Yamamoto
Noriko Yamamoto
TSTakeshi Sano
Takeshi Sano
Okumura Y, et al. J Gastric Cancer. 2018 Aug;18:e22. https://doi.org/10.5230/jgc.2018.18.e22

6 September 2012 in Radiological Physics and Technology
Verified
Journal Article
Closed access
PDF file
KUKeisuke Usui
Keisuke Usui
YIYasunobu Ichimaru
Yasunobu Ichimaru
YOYasuhiro Okumura
Yasuhiro Okumura
KMKatsuki Murakami
Katsuki Murakami
MSMakoto Seo
Makoto Seo
KOKoichi Ogawa
Koichi Ogawa

29 April 2024 in Cancers
Verified
Journal Article
Open access
PDF file
ATAndrianos Tsekrekos
Andrianos Tsekrekos
YOYasuhiro Okumura
Yasuhiro Okumura
IRIoannis Rouvelas
Ioannis Rouvelas
MNMagnus Nilsson
Magnus Nilsson
Significant progress has been made in the surgical management of gastric cancer over the years, and previous discrepancies in surgical practice between different parts of the world have gradually lessened. A transition from the earlier period of progressively more extensive surgery to the current trend of a more tailored and evidence-based approach is clear. Prophylactic resection of adjacent anatomical structures or neighboring organs and extensive lymph node dissections that were once assumed to increase the chances of long-term survival are now performed selectively. Laparoscopic gastrectomy has been widely adopted and its indications have steadily expanded, from early cancers located in the distal part of the stomach, to locally advanced tumors where total gastrectomy is required. In parallel, function-preserving surgery has also evolved and now constitutes a valid option for early gastric cancer. Pylorus-preserving and proximal gastrectomy have improved the postoperative quality of life of patients, and sentinel node navigation surgery is being explored as the next step in the process of further refining the minimally invasive concept. Moreover, innovative techniques such as indocyanine green fluorescence imaging and robot-assisted gastrectomy are being introduced in clinical practice. These technologies hold promise for enhancing surgical precision, ultimately improving the oncological and functional outcomes.

6 January 2013 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MIMakoto Ishitobi
Makoto Ishitobi
YOYasuhiro Okumura
Yasuhiro Okumura
NANobuyuki Arima
Nobuyuki Arima
AYAtsushi Yoshida
Atsushi Yoshida
KNKatsuhiko Nakatsukasa
Katsuhiko Nakatsukasa
HIHideo Inaji
Hideo Inaji

2 December 2015 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
YOYasuhiro Okumura
Yasuhiro Okumura
SASusumu Aikou
Susumu Aikou
HOHaruna Onoyama
Haruna Onoyama
KJKeiichi Jinbo
Keiichi Jinbo
YYYukinori Yamagata
Yukinori Yamagata
YSYasuyuki Seto
Yasuyuki Seto
Gastric cancer exhibits various degrees of fluorine F-18 fluorodeoxyglucose (18F-FDG) uptake on positron emission tomography/computed tomography (PET/CT). We evaluated the relationship between 18F-FDG uptake and the presence/absence of metastasis in individual lymph nodes (LN) on a one-to-one basis. We analyzed 21 patients with gastric cancer. We injected 18F-FDG intravenously in the morning, and gastrectomy with LN dissection was performed in the afternoon of the same day. Radiation doses were measured at each LN using a well-type counter, and we then compared 18F-FDG uptake, the shortest diameter, and pathological examination results for each LN. In our study, 906 LNs were analyzed, including 115 metastatic LNs. Metastatic LNs showed significantly higher 18F-FDG uptake (P < 0.0001), and were significantly enlarged (P < 0.0001). The receiver operating characteristics (ROC) curve had a larger area under the curve (0.71) for 18F-FDG uptake than for the shortest LN diameter (0.60). Considering histology, the ROC curve for intestinal type adenocarcinoma had a larger area under the curve than that for diffuse type (0.75 vs 0.61). F-FDG uptake is potentially a more useful variable than LN diameter for discriminating between LN with and without metastasis, especially in intestinal type gastric cancer cases.